Data / Form D filings / Profound Medical Corp.
Profound Medical Corp.: Form D filings
Profound Medical Corp., a biotechnology company in Mississauga, Ontario, Canada, filed 2 Form D notices with the SEC in 2017. The latest, on October 5, 2017, reports $877,471 sold of a $877,471 offering to 16 investors.
Find out what Profound Medical Corp. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2400 SKYMARK AVENUE, UNIT 6, Mississauga, Ontario, Canada, L4W 5
- Phone
- (647) 476-1350
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Ontario, Canada
- Year incorporated
- 2015
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1628808
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 5, 2017 | Amendment | $877,471 | $877,471 | $0 | 16 | Sep 20, 2017 | sec.gov |
| Oct 5, 2017 | New notice | $877,471 | $877,471 | $0 | 16 | Sep 20, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jean-Francois Pariseau | Director | |
| Damian Lamb | Director | |
| Arun Menawat | Executive Officer, Director | |
| William Curran | Director | |
| Samira Sakhia | Director | |
| Kenneth Galbraith | Director | |
| Rashed Dewan | Executive Officer |
Every Form D from the week of Oct 2, 2017 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Profound Medical Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.